sleeve in 2017, lowest 168, back to 198 when I started tirz in march 2024, currently sitting at 175 which is literally the number I said I wanted. so why am I still researching tesamorelin. here’s the thing that doesn’t get talked about enough for post-sleeve people: the weight I regained during the pandemic distributed differently than my pre-surgery weight did. back at 312, I carried it everywhere. the 58 lbs I regained went almost entirely to my abdomen, and even at 175 right now, my waist-to-hip ratio looks different than it did the last time I was 175. I brought this up to my bariatric surgeon last month. she said what I expected - tirz is doing the heavy lifting, stay the course, give it more time. but she also didn’t dismiss the visceral fat question, which I appreciated. she mentioned that some of her post-WLS patients who plateau with stubborn central adiposity have had conversations about GHRH options, tesamorelin specifically, as an adjunct. not as a replacement for the GLP-1. that framing matters. the tesa-or-reta question assumes you’re choosing between two tools. for me the real question is whether tesamorelin adds anything on top of what tirz is already doing, specifically for that redistributed visceral fat pattern that seems common after sleeve regain. I haven’t done anything yet. still at 10mg tirz, 6 weeks at this dose. going to give it another 8 weeks before I make any decisions. but the research rabbit hole is real and the post-bariatric angle on GHRH stacking is basically absent from these threads.